Zhengye Biotechnology Holding (ZYBT) Equity Average (2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Zhengye Biotechnology Holding (ZYBT) has disclosed Equity Average for 1 consecutive years, with $43.5 million as the latest value for Q4 2024.

• Quarterly Equity Average changed N/A to $43.5 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $43.5 million through Dec 2024, changed N/A year-over-year, with the annual reading at $38.8 million for FY2024, 15.53% down from the prior year.
• Equity Average for Q4 2024 was $43.5 million at Zhengye Biotechnology Holding.
• The five-year high for Equity Average was $43.5 million in Q4 2024, with the low at $43.5 million in Q4 2024.

Peer Comparison